2009 - Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis

Siragusa, Sergio
July 2009
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p3
Academic Journal
The article focuses on a study investing reduction of catheter-related thrombosis by warfarin compared with no warfarin, or by dose-adjusted warfarin compared with fixed-dose warfarin in patients with cancer receiving chemotherapy through central venous catheters (CVCs). The results concluded that warfarin did not affect risk for catheter-related thrombosis.


Related Articles

  • Cisplatin/etoposide.  // Reactions Weekly;12/1/2007, Issue 1180, p11 

    The article describes the case of a 33-year-old man who developed cerebral dural sinus thrombosis after receiving cisplatin-based chemotherapy for testicular germ cell cancer. The patient developed repetitive partial seizures, severe headache, , right hemiplegia and bilateral papillary oedema...

  • Which patients receiving warfarin can be treated safely with a drug-eluting stent? Ryding, A. D. S.; Banning, A. P. // Heart;Mar2008, Vol. 94 Issue 3, p275 

    The article presents information on the effectiveness of warfarin with a combination of a drug-eluting stent (DES) technology. It discusses the emergence and effectiveness of the DES technology replacing the in-stent restenosis. However, the problem in stent thrombosis has been cited due to the...

  • Prophylaxis of catheter-related venous thrombosis in cancer patients. Meinolf Karthaus // Supportive Care in Cancer;Jul2008, Vol. 16 Issue 7, p787 

    Abstract Background  The use of indwelling central venous catheters (CVCs) for chemotherapy delivery is common practice in cancer patients. Central venous lines facilitate ease of blood drawing along with administration of blood products and various other therapies. Significant risks,...

  • Factor V Leiden and prothrombin mutation linked to venous thrombosis.  // Hem/Onc Today;2/10/2008, Vol. 9 Issue 2, p29 

    The article discusses a study concerning the association of Factor V Leiden and prothrombin mutation to venous thrombosis, which was published in the "Journal of Thrombosis & Haemostasis." A meta-analysis of studies was performed in Italy to measure the incidence of prethrombotic abnormalities...

  • Economical anticoagulation depends on age, sex.  // PharmacoEconomics & Outcomes News;8/13/2005, Issue 484, p10 

    Discusses a study on oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Factors associated with the cost effectiveness of anticoagulation strategies in patients who have experienced a first idiopathic venous thromboembolic event; Use of a Markov model in the...

  • Review: Several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p76 

    The article addresses the question as to which factors are associated with the performance of D-dimer assays for detecting lower-extremity deep venous thrombosis (DVT) in symptomatic patients. The article adds that in symptomatic patients, biochemical and technical characteristics of the assays,...

  • Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease. Womack, Christopher; Nagelkirk, Paul R.; Coughlin, Adam M. // Sports Medicine;2003, Vol. 33 Issue 11, p795 

    Highlights the clinical significance of coagulation and fibrinolytic responses, and adaptations in healthy individuals and patients with cardiovascular disease. Responses of coagulation to exercise; Exercise responses in fibrinolysis; Indicators of the potential for coagulation and fibrinolysis.

  • Prognostic Index for Survival in Patients After Treatment for Primary Hepatocellular Carcinoma. Mari Kogo; Ayuko Kano; Yuji Kiuchi; Keiji Mitamura; Keiichiro Yoneyama // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2444 

    Abstract  We retrospectively evaluated clinical factors affecting long-term survival after treatment for hepatocellular carcinoma (HCC) to predict the reliability of the prognosis of patients with HCC. We analyzed 157 patients who received treatment for HCC. The prognostic index...

  • A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Lanuke, Kathryn; Mack, Lloyd A.; Temple, Walley J. // Canadian Journal of Surgery;Feb2009, Vol. 52 Issue 1, p18 

    Background: We sought to investigate the incidence of perioperative venous thromboembolism (VTE) — pulmonary embolism, superior mesenteris vein thrombosis and deep vein thrombosis — in patients with peritoneal carcinomatosis after cytoreductive surgery combined with hyperthermic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics